Celemin 5S

Quick links

Choose a section

Quick links to important sections

Advertisements

Celemin 5S

Advertisements
Advertisements

Treatment option:

Advertisements

Overview of Celemin 5S

Quick Facts about Celemin 5S

Property Description
Active ingredient L-Amino Acids (a balanced mixture)
Form Sterile Solution for Infusion
Pharmacological class Amino Acid Solutions for Parenteral Nutrition
Common use Nutritional support and maintenance of protein balance
Origin Synthetic, pharmaceutical-grade L-amino acids

1. Understanding Celemin 5S: Definition and Classification

Celemin 5S is a specialized, sterile solution intended for intravenous (IV) infusion, classified as a prescription-only (Rx) parenteral nutritional supplement. It is a brand marketed by manufacturers such as Claris Lifesciences and Otsuka. The medicine belongs to the pharmacological class of Amino Acid Solutions for Parenteral Nutrition. This type of therapy is an essential component for managing patients who require immediate and reliable protein delivery directly into the bloodstream. The "5S" in the name typically refers to the 5% (w/v) concentration of amino acids in the final solution.

2. Composition and Source: The Celemin 5S Difference

Celemin 5S is composed of a precise, pharmaceutical-grade blend of essential and non-essential L-amino acids, which are the fundamental building blocks of protein. These amino acids are produced synthetically in a controlled environment, ensuring high purity and stability. A distinguishing feature of some Celemin 5S formulations is the potential inclusion of Sorbitol, which can serve as an additional carbohydrate source. This combination makes it suitable for use as both a primary nitrogen source and a caloric component. These solutions provide the necessary nitrogen in nutritional regimens for critically ill patients.

3. Therapeutic Goal: Why is Celemin 5S Prescribed?

The primary therapeutic purpose of Celemin 5S is to prevent or correct a negative nitrogen balance in patients, ensuring protein reserves are maintained. This is particularly vital in catabolic states—a severe, typical use scenario—such as following major surgery or in cases of extensive burns. By supplying ready-to-use amino acids directly, Celemin 5S supports the body's capacity for tissue repair, immune function, and the synthesis of crucial enzymes and hormones, which are all critically impaired during periods of severe physiological stress.

Advertisements

What side effects are possible with Celemin 5S?

Possible side effects and safety information: Celemin 5S

This section outlines the officially documented safety profile of Celemin 5S (Amino Acid Solutions for Parenteral Nutrition), as detailed in regulatory documents from government health authorities.


General and Infusion-Related Adverse Reactions

The safety profile includes expected reactions that are often associated with the process or rate of infusion. These are generally classified in regulatory documents under General Disorders and Administration Site Conditions or Gastrointestinal Disorders.

Officially documented side effects include:

  • Fever (Pyrexia) and chills
  • Nausea and vomiting
  • Headache
  • Flushing (reddening of the skin) and increased sweating

These effects may be more likely to occur if the solution is administered too rapidly, a pattern explicitly noted in prescribing information.


Serious Metabolic Safety Concerns

The use of amino acid solutions in parenteral nutrition carries a regulatory mention of potential serious metabolic complications, particularly when the body’s clearance capacity is compromised. Serious adverse reactions documented in official labeling include metabolic acidosis, azotemia (excessive nitrogen compounds in the blood), and hyperammonemia (excess ammonia in the blood).


Safety Constraints and Population-Specific Notes

Regulatory documents establish specific constraints for use. The medicine is generally restricted for individuals with inborn errors of amino acid metabolism or a known hypersensitivity to any component. Explicit safety notes apply to patients with severe hepatic impairment, due to the increased risk of precipitating or aggravating hyperammonemia, and those with severe renal impairment.

Advertisements

Overdose and Emergency Response

The official overdose profile for Celemin 5S (L-Amino Acids Solution for Infusion) is defined by the consequences of administering the solution at an excessive rate or volume, leading to an overload of amino acids and fluid.

Documented Overdose Manifestations

Documented manifestations of over-infusion include clinical signs of intolerance such as nausea, vomiting, shivering, headache, and generalized flushing. Physiologically, overdose may present as hyperhydration and disturbances in metabolic balance, specifically metabolic acidosis and electrolyte imbalance.

Severe Outcomes and High-Risk Populations

Severe outcomes are generally linked to fluid and nitrogen overload. These may involve serious congested states, including pulmonary oedema. A critical concern is hyperammonemia (excess ammonia), which is associated with neurological complications like stupor or coma, particularly in patients with pre-existing hepatic insufficiency. Patients with impaired renal function face an elevated risk of retaining nitrogen metabolites.

Required Emergency Action

Regulatory guidance strictly mandates that the infusion must be discontinued immediately upon observation of any overdose symptoms. The patient’s clinical status requires prompt re-evaluation by a healthcare professional. While no specific antidote is known, management involves supportive general measures, including close biochemical monitoring and the appropriate treatment of specific abnormalities.

Advertisements

Therapeutic Uses of Celemin 5S

What Celemin 5S treats: main uses and benefits

Celemin 5S is primarily used for supportive nutritional assistance in conditions where patients may not be able to consume adequate nutrients orally, such as during intestinal failure or periods requiring bowel rest. This preparation is applied within the framework of parenteral nutrition.

Amino acid solutions help address symptom clusters that may become intense or disruptive, supporting the body's fundamental metabolic needs in situations of nutritional deficit. This preparation is considered relevant in conditions presenting with acute episodes, for example, those involving major surgical procedures, severe trauma, or extensive burns. It assists with maintaining functional stability in patients experiencing symptoms related to systemic imbalance linked to nutritional deficiencies and is commonly used in settings marked by temporary physiological imbalance.

It is applied across domains where additional symptomatic support is needed, and may assist with managing symptoms related to systemic imbalance associated with nutritional deficiencies, severe physiological strain, and functional stability issues linked to impaired gastrointestinal absorption. A key advantage is that it contributes to easing the overall symptom load for patients undergoing periods of heightened physiological stress. It is relevant in contexts involving heightened systemic burden.


Quick Fact: Relief for Symptoms Related to Systemic Imbalance

Advertisements

Eligibility and Restrictions for Use

Eligibility for Celemin 5S: Official Regulatory Status

Celemin 5S (an amino acid solution for parenteral nutrition) is generally allowed for adult patients requiring nutritional support due to inability to consume or absorb sufficient nutrients orally. However, regulatory documents place clear restrictions on its use.

Absolute Contraindications

The medicine is absolutely prohibited in patients with the following conditions, as stated in official prescribing information:

  • Known hypersensitivity or allergy to any component of the solution.
  • Inborn errors of amino acid metabolism incompatible with the product's specific profile.
  • Severe, uncorrected metabolic acidosis or uncompensated circulatory instability (e.g., shock).
  • Hepatic coma (severe, end-stage liver failure).

Restricted and Conditional Use

Use is restricted and requires cautious monitoring or specialized formulations in these populations:

  • Severe Renal Impairment: Requires careful adjustment of fluid and electrolyte balance; standard formulas may be contraindicated in anuric patients not on dialysis.
  • Pediatric Patients: Use is permitted, but the dosage and infusion rate must be meticulously adjusted according to the patient's weight, age, and fluid status.
  • Pregnancy and Lactation: Use is classified as Pregnancy Category C; it is permitted only if the potential benefit justifies the potential risk to the fetus or nursing infant, as defined by regulatory guidance.
Advertisements

What should I know about interactions with other medicines?

The interaction profile of Celemin 5S is primarily defined by the pharmacokinetic characteristics of its core component, Selenium, which is subject to urinary excretion and can be influenced by co-administered medicinal products.

Mechanism of Interaction

The most commonly documented interaction mechanism involves the alteration of the excretion rate of the component Selenium, or conversely, Selenium’s effect on the excretion of other medicines. Certain medicinal product categories, including various NSAIDs, beta-agonists, antivirals, antidepressants, and antibiotics, may decrease the renal excretion rate of Selenium, potentially leading to increased serum levels of Celemin 5S components. Conversely, drugs like carbonic anhydrase inhibitors (e.g., Acetazolamide) or certain diuretics (e.g., Amiloride) may increase the excretion rate of Selenium, which could result in lower serum levels and a potential reduction in therapeutic effect.

Interacting Product Classes

Additionally, due to its properties as a polyvalent cation source, Celemin 5S may decrease the absorption and overall systemic exposure of various co-administered medicinal products via chelation or binding in the gastrointestinal tract. Specific drug classes that may be affected by this principle include certain bisphosphonates (e.g., Alendronate) and some antiretroviral agents (e.g., Raltegravir, Bictegravir). These combinations may require specific timing-based separation (e.g., administering the interacting medicine two to six hours apart) to minimize the reduction in absorption. Consultation with a healthcare provider is essential for assessing these potential interactions.

Advertisements

Mechanism of Action

Celemin 5S delivers a mixture of essential and non-essential amino acids directly into the systemic circulation via intravenous administration. This route bypasses the gastrointestinal tract, ensuring the immediate and complete availability of these precursors within the plasma amino acid pool.

The presence of these amino acids is essential for their function as foundational substrates, engaging the cellular machinery required for protein biosynthesis. Their availability directly modulates intracellular signaling pathways that govern protein turnover, shifting the balance away from catabolic processes. This mechanistic cascade, involving the sustained synthesis of new cellular and structural proteins, facilitates the maintenance of a positive nitrogen balance. The resulting physiological consequence is the direct provision of the necessary building blocks for tissue integrity and continued metabolic function at the cellular level.

Advertisements

Dosage and Administration Information

How to Use Celemin 5S

Celemin 5S, an amino acid solution for parenteral nutrition, is used according to strict guidelines to ensure precise administration of protein building blocks.


Administration Protocol

The medicine is administered exclusively via Intravenous (IV) Infusion. Due to its formulation as a sterile solution, it is intended for use within a supervised clinical setting, such as a hospital. Lower concentration solutions, like 5% Celemin, may be administered via a peripheral vein, though central venous access is used when combined with concentrated dextrose to form Total Parenteral Nutrition (TPN). Strict aseptic technique is mandatory for all preparation and administration procedures.


Dosing and Scheduling

The dosage of Celemin 5S is not fixed but is highly individualized and based on the patient's daily protein needs, metabolic status, and body weight. Typical adult regimens range from 0.8 to 2.5 grams of amino acids per kilogram of body weight per day, with the higher end reserved for patients in hypercatabolic states. The solution is administered as a continuous infusion, often over a period of 14 to 24 hours daily, with a specific maximum hourly infusion rate that must not be exceeded.


Administration Conditions

For the body to utilize the amino acids effectively for protein synthesis, Celemin 5S must be infused concurrently with adequate non-protein calorie sources, such as fat emulsions or dextrose. Dosage adjustments are a key procedural requirement for specific populations, including pediatric patients and older adults, and are also necessary in cases of renal or hepatic impairment.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Celemin 5S

Evidence for Use in Standard Nutritional Support

Research into amino acid solutions for parenteral nutrition (the category to which Celemin 5S belongs) was studied for its application as a nutritional component when people cannot eat or absorb adequate nutrients through the digestive system. This fundamental research involves Systematic Reviews and Observational Cohort Studies that inform major clinical guidelines. Studies examined patient populations requiring intravenous feeding, with researchers tracking Nitrogen Balance as a measured outcome. The principal measurements tracked were Nitrogen Balance, Protein Synthesis, and concentrations of Plasma Amino Acids.

The findings describe patterns observed in the studies where providing amino acids intravenously was studied for its association with Nitrogen Equilibrium. This evidence contributes to the broader evidence landscape but is limited regarding the specific applicability of different commercial amino acid blends.


Research in Acute Catabolic States and Critical Illness

Research was studied for its application in settings such as major trauma, extensive burns, or critical care. This research often involves Randomized Controlled Trials (RCTs) alongside Prospective Observational Studies. Researchers examined outcomes related to Mortality (tracked at 30, 90, and 180 days), ICU Length of Stay, and functional measures like physical recovery.

Findings were mixed across different studies when comparing various levels of total protein dose, particularly in critically ill patients. Some trials described patterns where Nitrogen Balance measurements changed, but research exploring how these changes translate into long-term patient outcomes was associated with inconsistent results. A key limitation is that large-scale, comparative evidence is lacking specifically on whether different amino acid compositions may lead to differences in major clinical outcomes for critically ill adults.


What is Still Uncertain About the Research for Celemin 5S

Current evidence is limited in several key areas. Comparative evidence is lacking for the specific formulation of Celemin 5S against other commercially available amino acid solutions; findings are often extrapolated from the general class of medicine. Additionally, subgroup findings are uncertain regarding the optimal dose and specific composition for all patient groups. Finally, the long-term effects are not fully established by research, as most rigorous studies focus on the short-term, acute care setting.

Key Studies & References

  1. ESPGHAN/ESPEN/ESPR guidelines on pediatric parenteral nutrition: Amino acids
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Celemin 5S (FAQ)

Q: Can I drive or operate machinery while using Celemin 5S?

Official safety information lists potential adverse reactions such as headache and nausea, and in some documented cases, confusion or drowsiness. If you experience these types of reactions, official information indicates that caution is appropriate, as they could affect alertness.

Q: Is there any research on Celemin 5S use during pregnancy (informational only)?

Regulatory guidance addresses the use of the medicine during pregnancy, stating it is permitted only if the potential benefit to the patient justifies the potential risk to the fetus. The decision for use in this circumstance is determined by a healthcare provider based on the clinical necessity of the nutritional support.

Q: Can I use Celemin 5S if I am breastfeeding (informational only)?

Official safety notes state that use during lactation is permitted only if the clinical benefit to the patient is considered to justify the potential risk to the nursing infant. The decision for use in this circumstance is determined by a healthcare provider.

Q: How long does Celemin 5S typically stay in the body after the last use?

The duration the medicine's components remain in the body is determined by its pharmacokinetics, which includes how quickly the body excretes the amino acids and their byproducts. Official documents containing this data would include the half-life of the active components.

Q: Can people with liver impairment use Celemin 5S?

Regulatory documents restrict the use for patients with severe hepatic impairment (severe liver problems) because of the increased risk of complications like hyperammonemia. Use in patients with non-severe impairment requires cautious use, which involves specialized monitoring and careful adjustment of nutritional intake.

Q: Can people with a history of kidney problems use Celemin 5S?

Use is restricted for patients with severe renal impairment (severe kidney problems), especially those who are not on dialysis, and requires cautious use and attention to fluid balance and nutritional status. For patients with a history of kidney issues, caution is advised.

Q: Does Celemin 5S affect mood or anxiety?

While mood changes or anxiety are not commonly listed as general side effects, official safety profiles have documented other effects on the Central Nervous System (CNS). These include reactions such as headache, confusion, or restlessness.

Q: Does official information about Celemin 5S mention weight change?

Official safety information for this class of medicine may list unusual weight gain or loss as a documented adverse reaction in the clinical data. However, the incidence of these effects may not be commonly reported by patients.

Q: Does Celemin 5S need to be stopped gradually?

Dosage and administration sections in regulatory documents may contain guidance on dose adjustment or tapering off procedures. The procedure is determined on a case-by-case basis by the supervising healthcare provider, as nutritional support is highly individualized.

Q: Is Celemin 5S considered a long-term treatment option?

According to official product information, the medicine is generally administered for as long as parenteral nutrition is required by the patient's medical condition. The overall duration of the treatment is determined by the patient’s nutritional needs and the clinical assessment by their provider.

Q: What happens if I miss a dose of Celemin 5S?

Regulatory guidance indicates that if a planned infusion is missed, patients should not attempt to compensate for a missed infusion. Instead, administration should proceed with the regular schedule as required by the treatment plan.

Q: Are there any common foods or drinks to avoid while using Celemin 5S?

Official summaries of product characteristics (SmPC) are required to provide information regarding any known interaction with food and drink, if applicable to the use of the medicine. Official documents can be reviewed for specific details on any applicable dietary restrictions during the infusion period.

Q: Is Celemin 5S a controlled substance?

Official labeling classifies this medicine as a prescription-only (Rx) product, meaning it is only available with a prescription. The active ingredients in this nutritional class are generally not scheduled under government controlled substance acts.

Q: What is the difference between the '5S' version and other versions of Celemin?

The '5S' typically refers to the 5% concentration of amino acids in the solution. Other versions of the medicine are distinguished by having different concentrations (such as 8%, 16%, or 25%) which are suitable for varying levels of patient protein requirements.

Q: Do patients typically need routine monitoring while on Celemin 5S?

Yes, official safety information indicates that frequent monitoring and evaluations are necessary. This is especially important during the initial days of therapy to check for potential complications such as fluid imbalance, blood sugar levels, and metabolic changes.

Q: What kind of research has been done on the long-term safety of Celemin 5S?

Research that informs regulatory use, such as Randomized Controlled Trials (RCTs), often focuses on the short-term, acute care setting. Regulatory documents state that the long-term effects are not fully established, which reflects the limits of the current, rigorous evidence base.

Q: What kind of patient populations were included in the main Celemin 5S studies?

Research has primarily examined patient populations requiring intravenous feeding, including those in critical care settings, or individuals who are in a catabolic state following major trauma or extensive burns. The studies focus on patients who require protein synthesis support.

Q: Is it normal to feel a mild headache when first starting Celemin 5S?

Headache is listed as an officially documented side effect associated with the infusion. Regulatory documents often note that these types of reactions may occur, particularly if the solution is administered too rapidly.

Advertisements

How should Celemin 5S be stored and disposed of?

How to Store and Dispose of Celemin 5S?

Celemin 5S, an amino acid solution for infusion, requires strict adherence to regulatory storage and disposal mandates to maintain its sterility and integrity.


Official Storage Requirements

Condition Requirement (Official Labeling)
Temperature Store at or below 25 C; Do not freeze.
Protection Solution must be protected from light and kept in its original outer carton.
Container Check Use only if the solution is clear, particle-free, and the container is undamaged.
Child Safety Keep out of the sight and reach of children.

Stability and Disposal Mandates

Celemin 5S is a single-use preparation. Any portion of the solution remaining in the container after treatment must be discarded immediately by a healthcare professional. Disposal of the unused product and associated equipment must follow approved hospital or local pharmaceutical waste procedures to ensure safety and environmental compliance. Special light protection is required during the administration of the solution to neonates and children under 2 years of age.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Celemin 5S found in:

A-Z Index: